Abstract

The COVID-19 pandemic exposed structural vulnerabilities in global supply chains, compelling firms to reevaluate their accounting strategies and cost management systems amid rising uncertainty. This study investigates how leading multinational companies across the manufacturing, pharmaceutical, automotive, and consumer goods sectors adapted their financial practices to mitigate risks associated with cost variability, inventory disruption, and supplier dependency. Through a qualitative comparative analysis of public financial disclosures and corporate case studies from 2020 to 2021, the research identifies key shifts in accounting practices including the adoption of flexible budgeting, rolling forecasts, activity-based costing, and scenario-driven supplier assessments.
The study introduces a conceptual framework that links cost accounting to operational resilience, emphasizing how revised inventory strategies, supplier diversification, and real-time financial modeling have redefined the role of accounting in crisis management. Case snapshots from Toyota, Pfizer, Unilever, and Intel illustrate how accounting systems were leveraged to support continuity, transparency, and long-term strategic planning. The findings contribute to post-pandemic accounting literature by framing cost management not merely as an efficiency mechanism but as a critical enabler of supply chain governance and resilience.
The paper concludes with actionable recommendations for redesigning cost allocation models, fostering supplier-level financial collaboration, and treating inventory as a financial hedge against disruption. It also outlines future research directions, particularly the integration of artificial intelligence (AI) and predictive analytics into dynamic cost forecasting systems.